{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T02:02:02Z","timestamp":1769738522071,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","award":["OG-3\u201310\u20133123- BP"],"award-info":[{"award-number":["OG-3\u201310\u20133123- BP"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","award":["17\u20132008\u2013715"],"award-info":[{"award-number":["17\u20132008\u2013715"]}],"id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jns.2017.05.053","type":"journal-article","created":{"date-parts":[[2017,5,25]],"date-time":"2017-05-25T19:15:47Z","timestamp":1495739747000},"page":"94-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy"],"prefix":"10.1016","volume":"379","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9020-2399","authenticated-orcid":false,"given":"Alon","family":"Abraham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ari","family":"Breiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans D.","family":"Katzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leif E.","family":"Lovblom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce A.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5805-4883","authenticated-orcid":false,"given":"Vera","family":"Bril","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 2","key":"10.1016\/j.jns.2017.05.053_bb0005","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.2337\/diab.46.2.S54","article-title":"Classification, differential diagnosis, and staging of diabetic peripheral neuropathy","volume":"46","author":"Thomas","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/j.jns.2017.05.053_bb0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410190503","article-title":"Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathy","volume":"19","author":"Dyck","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jns.2017.05.053_bb0020","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1388-2457(98)00028-5","article-title":"Chronic inflammatory demyelinating polyneuropathy in diabetics: motor conductions are important in the differential diagnosis with diabetic polyneuropathy","volume":"110","author":"Uncini","year":"1999","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2017.05.053_bb0025","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2017.05.053_bb0030","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.diabres.2012.11.006","article-title":"By the numbers: new estimates from the IDF Diabetes Atlas Update for 2012","volume":"98","author":"Guariguata","year":"2012","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.jns.2017.05.053_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1212\/WNL.0000000000001160","article-title":"Incidence of polyneuropathy in Utrecht, the Netherlands","volume":"84","author":"Visser","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.05.053_bb0040","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1212\/WNL.45.10.1832","volume":"45","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.05.053_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/ageing\/15.4.247","article-title":"Causes of polyneuropathy in the elderly","volume":"15","author":"George","year":"1986","journal-title":"Age Ageing"},{"key":"10.1016\/j.jns.2017.05.053_bb0050","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.21.10.1749","article-title":"Glycemic control is related to the electrophysiologic severity of diabetic peripheral sensorimotor polyneuropathy","volume":"21","author":"Tkac","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2017.05.053_bb0055","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jns.2017.05.053_bb0060","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.2337\/dc09-1941","article-title":"Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study","volume":"33","author":"Albers","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2017.05.053_bb0065","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1046\/j.1464-5491.2002.00778.x","article-title":"Longitudinal assessment of the development of diabetic polyneuropathy and associated risk factors","volume":"19","author":"van de Poll-Franse","year":"2002","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0070","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/WNP.0b013e31819862ee","article-title":"Elevated glycosylated hemoglobin is associated with subclinical neuropathy in neurologically asymptomatic diabetic patients: a prospective study","volume":"26","author":"El-Salem","year":"2009","journal-title":"J. Clin. Neurophysiol."},{"key":"10.1016\/j.jns.2017.05.053_bb0075","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1007\/s11926-004-0075-3","article-title":"Serum uric acid-lowering therapies: where are we heading in management of hyperuricemia and the potential role of uricase","volume":"6","author":"Bomalaski","year":"2004","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jns.2017.05.053_bb0080","first-page":"1","article-title":"Effect of uric acid-lowering therapy on blood pressure: systematic review and meta-analysis","author":"Qu","year":"2016","journal-title":"Ann. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0085","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijcard.2015.08.088","article-title":"Uric acid lowering therapy in cardiovascular diseases","volume":"213","author":"Volterrani","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2017.05.053_bb0090","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/JIM.0000000000000242","article-title":"Lowering uric acid with allopurinol improves insulin resistance and systemic inflammation in asymptomatic hyperuricemia","volume":"63","author":"Takir","year":"2015","journal-title":"J. Investig. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0095","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1007\/s00415-014-7331-x","article-title":"Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis","volume":"261","author":"Abraham","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.jns.2017.05.053_bb0100","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/0003319710394164","article-title":"Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus","volume":"62","author":"Papanas","year":"2011","journal-title":"Angiology"},{"key":"10.1016\/j.jns.2017.05.053_bb0105","first-page":"17","article-title":"Association between serum uric acid level and diabetic peripheral neuropathy (a case control study)","volume":"5","author":"Kiani","year":"2014","journal-title":"Caspian J. Intern. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0110","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s12035-014-9075-0","article-title":"Serum uric acid levels and diabetic peripheral neuropathy in type 2 diabetes: a systematic review and meta-analysis","volume":"53","author":"Yu","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.jns.2017.05.053_bb0115","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/mus.24978","article-title":"Frequent laboratory abnormalities in CIDP patients","volume":"53","author":"Abraham","year":"2016","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2017.05.053_bb0120","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab. Res. Rev."},{"key":"10.1016\/j.jns.2017.05.053_bb0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165731","article-title":"Laser doppler flare imaging and quantitative thermal thresholds testing performance in small and mixed fiber neuropathies","volume":"11","author":"Abraham","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jns.2017.05.053_bb0130","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1586\/1744666X.2015.1018891","article-title":"Treatment responsiveness in CIDP patients with diabetes is associated with unique electrophysiological characteristics, and not with common criteria for CIDP","volume":"11","author":"Abraham","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jns.2017.05.053_bb0135","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1002\/mus.880160711","article-title":"Assessment of diabetic neuropathy: definition of norm and discrimination of abnormal nerve function","volume":"16","author":"Claus","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.jns.2017.05.053_bb0140","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1212\/WNL.59.4.611","article-title":"Comparison of sensory testing on different toe surfaces: implications for neuropathy screening","volume":"59","author":"Dimitrakoudis","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.05.053_bb0145","series-title":"Neuromuscular Disorders","author":"Russell","year":"2015"},{"key":"10.1016\/j.jns.2017.05.053_bb0150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.exger.2016.07.002","article-title":"Serum uric acid concentrations and risk of frailty in older adults","volume":"82","author":"Garc\u00eda-Esquinas","year":"2016","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.jns.2017.05.053_bb0155","article-title":"Hyperuricemia is a significant predictor of poor physical performance in the elderly: THE Pro.V.A. Study","author":"Veronese","year":"2016","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"10.1016\/j.jns.2017.05.053_bb0160","first-page":"1","article-title":"Associations between serum uric acid levels and the incidence of nonfatal stroke: a nationwide community-based cohort study","author":"Kamei","year":"2016","journal-title":"Clin. Exp. Nephrol."},{"key":"10.1016\/j.jns.2017.05.053_bb0165","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2337\/diacare.25.3.565","article-title":"Carpal tunnel syndrome in patients with diabetic polyneuropathy","volume":"25","author":"Perkins","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jns.2017.05.053_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/dme.12855","article-title":"Diabetes as a risk factor for carpal tunnel syndrome: a systematic review and meta-analysis","volume":"33","author":"Pourmemari","year":"2016","journal-title":"Diabet. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0175","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ijcard.2015.08.110","article-title":"Relation of serum uric acid to cardiovascular disease","volume":"213","author":"Wu","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.jns.2017.05.053_bb0180","doi-asserted-by":"crossref","first-page":"28549","DOI":"10.1038\/srep28549","article-title":"Serum uric acid levels were dynamically coupled with hemoglobin A1c in the development of type 2 diabetes","volume":"6","author":"Wei","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jns.2017.05.053_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF01221964","article-title":"Diabetes, prediabetes and uricaemia","volume":"12","author":"Herman","year":"1976","journal-title":"Diabetologia"},{"key":"10.1016\/j.jns.2017.05.053_bb0190","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0195","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1212\/WNL.31.11.1480","article-title":"Prevalence of monoclonal protein in peripheral neuropathy","volume":"31","author":"Kelly","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2017.05.053_bb0200","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2008.08.033","article-title":"Relationship of ethnic origin, gender, and age to blood creatine kinase levels","volume":"122","author":"Neal","year":"2009","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jns.2017.05.053_bb0205","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/j.1468-1331.2010.03012.x","article-title":"EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia","volume":"17","author":"Kyriakides","year":"2010","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jns.2017.05.053_bb0210","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archneur.1984.04050170057018","article-title":"Pain in Guillain-Barr\u00e9 syndrome","volume":"41","author":"Ropper","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jns.2017.05.053_bb0215","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1093\/brain\/awg012","article-title":"Demyelinating and axonal features of Charcot-Marie-tooth disease with mutations of myelin-related proteins (PMP22, MPZ and Cx32): a clinicopathological study of 205 Japanese patients","volume":"126","author":"Hattori","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2017.05.053_bb0220","first-page":"1","article-title":"Serum markers of inflammation and oxidative stress in sarcopenia","author":"Can","year":"2016","journal-title":"Aging Clin. Exp. Res."},{"key":"10.1016\/j.jns.2017.05.053_bb0225","first-page":"365","article-title":"Pathogenesis of diabetic neuropathy","volume":"4","author":"Feldman","year":"1997","journal-title":"Clin. Neurosci."},{"key":"10.1016\/j.jns.2017.05.053_bb0230","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.2040-1124.2010.00070.x","article-title":"Mechanism of diabetic neuropathy: where are we now and where to go?","volume":"2","author":"Yagihashi","year":"2011","journal-title":"J. Diabetes Investig."},{"key":"10.1016\/j.jns.2017.05.053_bb0235","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1080\/15257770802138558","article-title":"Uric acid: the oxidant-antioxidant paradox","volume":"27","author":"Sautin","year":"2008","journal-title":"Nucleosides Nucleotides Nucleic Acids."},{"key":"10.1016\/j.jns.2017.05.053_bb0240","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/jns.12154","article-title":"Small and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up study","volume":"21","author":"L\u00f8seth","year":"2016","journal-title":"J. Peripher. Nerv. Syst."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730357X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X1730357X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T08:03:45Z","timestamp":1655366625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X1730357X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":48,"alternative-id":["S0022510X1730357X"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2017.05.053","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Uric acid levels correlate with the severity of diabetic sensorimotor polyneuropathy","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2017.05.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}